Eating disorders in the ambulance of pediatric and adolescence gynecology.

Objective: To present a comprehensive overview of the female adolescent population focused on physical development and reproductive healthcare.

Methods: A summary of available literature using our own experience with the treatment of patients with eating disorders.

Conclusion: Approximately 0.

Postmenarcheal irregularities in menstrual cycle in adolescent girls.

The first menstrual bleeding, referred to as menarche, albeit an important point in a woman's life, does not yet mean her full sexual maturity. The hypothalamus-pituitary-ovary axis is fragile during this period and depends on many factors. Their mutual interplay occurs individually and gradually over the next few years, therefore menstrual irregularities of the menstrual cycle occur physiologically, and not all of them need to be regulated.

Therapy-Induced Growth and Sexual Maturation in a Developmentally Infantile Adult Patient with a PROP1 Mutation.

Background: Hypopituitarism as a result of PROP1 (prophet of PIT1) mutation represents the most common genetic cause of combined deficiency of pituitary hormones and due to growth retardation it is typically diagnosed in childhood.

Case Description: We present a unique case report of a prepubertal woman with growth retardation in whom combined pituitary hormone deficiency [central hypopituitarism, hypogonadism, and growth hormone (GH) deficiency] caused by homozygous mutation c.150delA in the PROP1 gene was diagnosed late in young adulthood due to unfavorable life circumstances.

Contribution of Hormonal Cytology in Girls and Adolescents to Reproductive Health: A Traditional Technique Monitoring Recent Problems.

Objective: To study the contribution of hormonal cytology in contemporary disturbances of fertility.

Design: Over a 10-year period (2006-2015), 6,688 vaginal fornix cytologies of 2,350 patients were investigated. For a more detailed analysis, a 3-year period from 2013 to 2015 was chosen.

The prevalence of HPV infections in HPV-vaccinated women from the general population.

Currently, three prophylactic HPV vaccines are commercially available to prevent HPV 16/18 infection and associated lesions. The aim of the study was to assess markers of HPV infection in women/girls before vaccination and to ascertain the prevalence and spectrum of post-vaccination HPV types. Three hundred and thirty subjects of which 75 were virgins were enrolled.